vs
CARRIAGE SERVICES INC（CSV）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
CARRIAGE SERVICES INC的季度营收约是RIGEL PHARMACEUTICALS INC的1.5倍（$105.5M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 11.6%，领先372.4%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 8.0%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 1.0%）
怡和Cycle & Carriage有限公司是怡和集团在东南亚的投资控股公司，目前该集团持有其75%的股份，是怡和集团在东南亚区域开展资本布局与投资业务的核心平台。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CSV vs RIGL — 直观对比
营收规模更大
CSV
是对方的1.5倍
$69.8M
营收增速更快
RIGL
高出13.2%
8.0%
净利率更高
RIGL
高出372.4%
11.6%
两年增速更快
RIGL
近两年复合增速
1.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $105.5M | $69.8M |
| 净利润 | $12.3M | $268.1M |
| 毛利率 | 34.8% | 91.5% |
| 营业利润率 | 23.3% | 33.2% |
| 净利率 | 11.6% | 384.0% |
| 营收同比 | 8.0% | 21.2% |
| 净利润同比 | 24.5% | 1769.2% |
| 每股收益（稀释后） | $0.76 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSVRIGL
| Q4 25 | $105.5M | $69.8M | ||
| Q3 25 | $102.7M | $69.5M | ||
| Q2 25 | $102.1M | $101.7M | ||
| Q1 25 | $107.1M | $53.3M | ||
| Q4 24 | $97.7M | $57.6M | ||
| Q3 24 | $100.7M | $55.3M | ||
| Q2 24 | $102.3M | $36.8M | ||
| Q1 24 | $103.5M | $29.5M |
净利润CSVRIGL
| Q4 25 | $12.3M | $268.1M | ||
| Q3 25 | $6.6M | $27.9M | ||
| Q2 25 | $11.7M | $59.6M | ||
| Q1 25 | $20.9M | $11.4M | ||
| Q4 24 | $9.9M | $14.3M | ||
| Q3 24 | $9.9M | $12.4M | ||
| Q2 24 | $6.3M | $-1.0M | ||
| Q1 24 | $7.0M | $-8.2M |
毛利率CSVRIGL
| Q4 25 | 34.8% | 91.5% | ||
| Q3 25 | 35.3% | 93.2% | ||
| Q2 25 | 35.2% | 95.6% | ||
| Q1 25 | 35.3% | 91.7% | ||
| Q4 24 | 34.4% | 89.9% | ||
| Q3 24 | 35.2% | 85.5% | ||
| Q2 24 | 36.2% | 92.4% | ||
| Q1 24 | 36.0% | 93.1% |
营业利润率CSVRIGL
| Q4 25 | 23.3% | 33.2% | ||
| Q3 25 | 17.0% | 40.9% | ||
| Q2 25 | 23.5% | 60.1% | ||
| Q1 25 | 29.5% | 23.9% | ||
| Q4 24 | 21.6% | 28.9% | ||
| Q3 24 | 22.7% | 25.4% | ||
| Q2 24 | 18.0% | 1.2% | ||
| Q1 24 | 18.8% | -23.6% |
净利率CSVRIGL
| Q4 25 | 11.6% | 384.0% | ||
| Q3 25 | 6.4% | 40.2% | ||
| Q2 25 | 11.5% | 58.6% | ||
| Q1 25 | 19.5% | 21.5% | ||
| Q4 24 | 10.1% | 24.9% | ||
| Q3 24 | 9.8% | 22.5% | ||
| Q2 24 | 6.1% | -2.8% | ||
| Q1 24 | 6.7% | -27.9% |
每股收益（稀释后）CSVRIGL
| Q4 25 | $0.76 | $14.11 | ||
| Q3 25 | $0.41 | $1.46 | ||
| Q2 25 | $0.74 | $3.28 | ||
| Q1 25 | $1.34 | $0.63 | ||
| Q4 24 | $0.62 | $0.82 | ||
| Q3 24 | $0.63 | $0.70 | ||
| Q2 24 | $0.40 | $-0.06 | ||
| Q1 24 | $0.45 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $254.8M | $391.5M |
| 总资产 | $1.3B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CSVRIGL
| Q4 25 | $1.7M | $155.0M | ||
| Q3 25 | $1.2M | $137.1M | ||
| Q2 25 | $1.4M | $108.4M | ||
| Q1 25 | $4.6M | $77.1M | ||
| Q4 24 | $1.2M | $77.3M | ||
| Q3 24 | $1.3M | $61.1M | ||
| Q2 24 | $1.5M | $49.1M | ||
| Q1 24 | $1.7M | $49.5M |
总债务CSVRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益CSVRIGL
| Q4 25 | $254.8M | $391.5M | ||
| Q3 25 | $242.1M | $117.6M | ||
| Q2 25 | $235.4M | $81.9M | ||
| Q1 25 | $223.1M | $18.6M | ||
| Q4 24 | $208.6M | $3.3M | ||
| Q3 24 | $198.1M | $-14.6M | ||
| Q2 24 | $187.9M | $-29.9M | ||
| Q1 24 | $179.6M | $-31.7M |
总资产CSVRIGL
| Q4 25 | $1.3B | $513.6M | ||
| Q3 25 | $1.3B | $242.5M | ||
| Q2 25 | $1.3B | $206.7M | ||
| Q1 25 | $1.3B | $176.0M | ||
| Q4 24 | $1.3B | $164.0M | ||
| Q3 24 | $1.3B | $139.4M | ||
| Q2 24 | $1.3B | $128.4M | ||
| Q1 24 | $1.3B | $126.5M |
负债/权益比CSVRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.1M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $6.2M | — |
| 自由现金流率自由现金流/营收 | 5.9% | — |
| 资本支出强度资本支出/营收 | 7.5% | — |
| 现金转化率经营现金流/净利润 | 1.15× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $40.1M | — |
8季度趋势，按日历期对齐
经营现金流CSVRIGL
| Q4 25 | $14.1M | $22.0M | ||
| Q3 25 | $24.7M | $24.0M | ||
| Q2 25 | $8.1M | $30.5M | ||
| Q1 25 | $13.8M | $-893.0K | ||
| Q4 24 | $9.3M | $14.5M | ||
| Q3 24 | $20.9M | $21.7M | ||
| Q2 24 | $2.2M | $302.0K | ||
| Q1 24 | $19.7M | $-5.0M |
自由现金流CSVRIGL
| Q4 25 | $6.2M | — | ||
| Q3 25 | $18.0M | — | ||
| Q2 25 | $5.2M | — | ||
| Q1 25 | $10.6M | — | ||
| Q4 24 | $4.9M | — | ||
| Q3 24 | $16.2M | — | ||
| Q2 24 | $-1.4M | — | ||
| Q1 24 | $16.2M | — |
自由现金流率CSVRIGL
| Q4 25 | 5.9% | — | ||
| Q3 25 | 17.5% | — | ||
| Q2 25 | 5.1% | — | ||
| Q1 25 | 9.9% | — | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | 16.1% | — | ||
| Q2 24 | -1.4% | — | ||
| Q1 24 | 15.6% | — |
资本支出强度CSVRIGL
| Q4 25 | 7.5% | — | ||
| Q3 25 | 6.5% | — | ||
| Q2 25 | 2.8% | — | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | 4.5% | — | ||
| Q3 24 | 4.6% | — | ||
| Q2 24 | 3.5% | — | ||
| Q1 24 | 3.4% | — |
现金转化率CSVRIGL
| Q4 25 | 1.15× | 0.08× | ||
| Q3 25 | 3.76× | 0.86× | ||
| Q2 25 | 0.69× | 0.51× | ||
| Q1 25 | 0.66× | -0.08× | ||
| Q4 24 | 0.94× | 1.01× | ||
| Q3 24 | 2.11× | 1.75× | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 2.83× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSV
| Propertyand Merchandise | $47.8M | 45% |
| Cemetery Interment Rights | $24.8M | 23% |
| Merchandise | $18.9M | 18% |
| Other Revenue | $10.2M | 10% |
| Other | $3.9M | 4% |
RIGL
暂无分部数据
